Slide Insurance (NYSE: SLDE) risk chief exercises options and sells 2,500 shares

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. Chief Risk Officer Matthew Paul Larson executed an option exercise-and-sale on June 1, 2026. He exercised stock options to acquire 2,500 shares of common stock at $0.79 per share and sold 2,500 shares in an open‑market transaction at $17.79 per share. The filing shows he holds 2,500 shares of common stock directly after these transactions and 8,998 stock options remain outstanding, expiring on February 24, 2032. The transactions were carried out under a pre‑arranged Rule 10b5-1 trading plan adopted on December 4, 2025, indicating they were scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 2,500 shares ($44,475)

Net Sell 3 txns

Insider LARSON MATTHEW PAUL

Role Chief Risk Officer

Sold 2,500 shs ($44K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	2,500	$0.00	--
Exercise	Common Stock	2,500	$0.79	$2K
Sale	Common Stock	2,500	$17.79	$44K

Holdings After Transaction: Stock Option (Right to Buy) — 8,998 shares (Direct, null); Common Stock — 2,500 shares (Direct, null)

Footnotes (1)

1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025. These stock options are fully vested and exercisable.

Key Figures

Shares sold: 2,500 shares Sale price: $17.79 per share Option exercise price: $0.79 per share +2 more

5 metrics

Shares sold 2,500 shares Common stock open-market sale on June 1, 2026

Sale price $17.79 per share Price for 2,500 Slide Insurance common shares sold

Option exercise price $0.79 per share Exercise price for 2,500 underlying common shares

Shares held after 2,500 shares Direct Slide Insurance common stock ownership post-transaction

Options remaining 8,998 options Fully vested Slide Insurance stock options expiring February 24, 2032

Key Terms

Rule 10b5-1 trading plan, open-market sale, Stock Option (Right to Buy), fully vested and exercisable

4 terms

Rule 10b5-1 trading plan financial

"Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

fully vested and exercisable financial

"These stock options are fully vested and exercisable."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LARSON MATTHEW PAUL

(Last) (First) (Middle)

4221 W BOY SCOUT BLVD

SUITE 200

(Street)

TAMPA FLORIDA 33607

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Risk Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		M		2,500	A	$0.79	2,500	D
Common Stock	06/01/2026		S		2,500(1)	D	$17.79	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.79	06/01/2026		M(1)			2,500	(2)	02/24/2032	Common Stock	2,500	$0	8,998	D

Explanation of Responses:

1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.

2. These stock options are fully vested and exercisable.

	/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SLDE Chief Risk Officer Matthew Larson report?

Matthew Larson reported exercising options for 2,500 Slide Insurance common shares and selling 2,500 shares in the open market. The combined exercise-and-sale occurred on June 1, 2026 as part of routine equity compensation activity disclosed in the Form 4 filing.

At what prices did Matthew Larson exercise and sell SLDE shares?

He exercised stock options at an exercise price of $0.79 per share and sold 2,500 Slide Insurance common shares at $17.79 per share. This reflects converting options into shares at a low strike price, then disposing of those shares at the prevailing market price.

How many Slide Insurance shares does Matthew Larson own after this Form 4?

After the reported transactions, Matthew Larson directly holds 2,500 shares of Slide Insurance common stock. The Form 4 also shows 8,998 stock options remaining outstanding, providing additional potential future share exposure if those options are exercised before expiration in 2032.

Were Matthew Larson’s SLDE trades made under a Rule 10b5-1 plan?

Yes. The filing footnotes state the options were exercised and the resulting shares sold pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025. Such pre-arranged plans schedule trades in advance, reducing the significance of trade timing as an informational signal.

What stock options does Matthew Larson retain in SLDE after this transaction?

Following the June 1, 2026 activity, he retains 8,998 Slide Insurance stock options. These options are fully vested and exercisable, with an exercise price of $0.79 per underlying share and an expiration date of February 24, 2032, according to the Form 4 disclosure.

Is Matthew Larson’s SLDE transaction primarily a sale or an acquisition?

Economically, the Form 4 reflects an exercise-and-sell pattern. He acquired 2,500 Slide Insurance shares by exercising options, then sold 2,500 shares in the open market, resulting in a net 2,500-share sale and increased reliance on remaining stock options for future exposure.